FDAClass IDecember 8, 2021

Enoxaparin Sodium Injection recall

Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Rx Only; 0.4 mL…

Why was Enoxaparin Sodium Injection recalled?

Temperature Abuse; temperature excursion during shipping

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #SAB06761A, exp 04/2023

Product
Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Rx Only; 0.4 mL…
Recalling firm
Sandoz Inc
Quantity
45,036 cartons
Distribution
Nationwide in the US
Recall date
December 8, 2021
Classification
Class I
Status
Completed
Agency
FDA (drug)
Open FDA enforcement record Latest recalls